These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults. Markowitz JS, Straughn AB, Patrick KS, DeVane CL, Pestreich L, Lee J, Wang Y, Muniz R. Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029 [Abstract] [Full Text] [Related]
3. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers. Wang Y, Lee L, Somma R, Thompson G, Bakhtiar R, Lee J, Rekhi GS, Lau H, Sedek G, Hossain M. Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557 [Abstract] [Full Text] [Related]
4. Development and validation of an UFLC-MS/MS method for enantioselectivity determination of d,l-thero-methylphenidate, d,l-thero-ethylphenidate and d,l-thero-ritalinic acid in rat plasma and its application to pharmacokinetic study. Zhang C, Luo H, Wu Y, Zhang J, Zhang F, Lin G, Wang H. J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb 01; 1011():45-52. PubMed ID: 26751592 [Abstract] [Full Text] [Related]
8. Stereoselective urinary pharmacokinetics of dl-threo-methylphenidate and its major metabolite in humans. Srinivas NR, Hubbard JW, Korchinski ED, Midha KK. J Pharm Sci; 1992 Aug 01; 81(8):747-9. PubMed ID: 1403717 [Abstract] [Full Text] [Related]
9. Nonlinear kinetics of threo-methylphenidate enantiomers in a patient with narcolepsy and in healthy volunteers. Aoyama T, Kotaki H, Sasaki T, Sawada Y, Honda Y, Iga T. Eur J Clin Pharmacol; 1993 Aug 01; 44(1):79-84. PubMed ID: 8436161 [Abstract] [Full Text] [Related]
11. Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject. Marchei E, Farrè M, Pellegrini M, García-Algar O, Vall O, Pacifici R, Pichini S. Forensic Sci Int; 2010 Mar 20; 196(1-3):59-63. PubMed ID: 20096514 [Abstract] [Full Text] [Related]
13. Determination of amphetamine and methylphenidate in exhaled breath of patients undergoing attention-deficit/hyperactivity disorder treatment. Beck O, Stephanson N, Sandqvist S, Franck J. Ther Drug Monit; 2014 Aug 20; 36(4):528-34. PubMed ID: 24452069 [Abstract] [Full Text] [Related]
14. Correlation between methylphenidate and ritalinic acid concentrations in oral fluid and plasma. Marchei E, Farré M, Pardo R, Garcia-Algar O, Pellegrini M, Pacifici R, Pichini S. Clin Chem; 2010 Apr 20; 56(4):585-92. PubMed ID: 20167695 [Abstract] [Full Text] [Related]
16. Enantioselective determination of methylphenidate and ritalinic acid in whole blood from forensic cases using automated solid-phase extraction and liquid chromatography-tandem mass spectrometry. Thomsen R, Rasmussen HB, Linnet K, INDICES Consortium. J Anal Toxicol; 2012 Oct 20; 36(8):560-8. PubMed ID: 22833645 [Abstract] [Full Text] [Related]
19. Development of analytical method for the determination of methylphenidate, the analog ethylphenidate and their metabolite ritalinic acid in oral fluid samples by micro-QuEChERS and liquid chromatography-tandem mass spectrometry. Chinaglia KO, Arantes ACF, Cunha KFD, Campos EG, Kahl JMM, Rodrigues LC, Costa JL. J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Aug 01; 1205():123330. PubMed ID: 35716546 [Abstract] [Full Text] [Related]